Clinical trials
catalyst calendar across sponsors →Studies where TCMD is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 with posted results
Held by 10 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., MARSHALL WACE, LLP, AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, +5 more) · FINRA short interest 11.5 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Flexitouch Treatment for Venous UlcersNCT00847002results2012-07-25Wound HealingRandomized · Open-label · Treatment | Not applicable | Terminatedsponsor's stated reason: Lack of Enrollment | Device: Standard Wound Care, Flexitouch System with Standard Wound Care | Venous Ulcer | 8 | Aug 2010actual | 2020-02-12 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19